You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Doxil

Showing 1 - 25 of 206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (Tucatinib, Doxil)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 17, 2023

Recurrent Ovarian Cancer Trial (DOXIL, Withaferin A, Ashwagandha)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • DOXIL
  • +3 more
  • (no location specified)
Jan 27, 2023

Ovarian Cancer, AIDS-related Kaposi Sarcoma, Multiple Myeloma Trial (DOXIL/CAELYX)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • (no location specified)
Jan 3, 2023

Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active, not recruiting
  • Soft Tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 25, 2023

CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

Recruiting
  • Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Pegylated Liposomal Doxorubicin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2023

Ovarian Cancer Trial (EC145, Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®), )

Terminated
  • Ovarian Cancer
  • (no location specified)
Sep 24, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (Pazopanib, Doxil)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Fort Myers, Florida
  • +3 more
Oct 4, 2021

Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

Not yet recruiting
  • Kaposi Sarcoma
  • HIV-1-infection
  • (no location specified)
Jan 20, 2023

Ovarian Cancer Trial in Indianapolis, Madison (Doxil (Pegylated Liposomal Doxorubicin), BIBF 1120)

Terminated
  • Ovarian Cancer
  • Doxil (Pegylated Liposomal Doxorubicin)
  • BIBF 1120
  • Indianapolis, Indiana
  • +1 more
Feb 14, 2022

Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)

Active, not recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +3 more
  • Valhalla, New York
    New York Medical College
Sep 27, 2022

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Breast Cancer Trial in New York (Coenzyme Q10, Coenzyme Q10 Placebo)

Completed
  • Breast Cancer
  • New York, New York
    Columbia University Medical Center
Oct 13, 2022

Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))

Not yet recruiting
  • Relapsed Sarcomas
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Apr 18, 2022

Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
Feb 4, 2021

Metastatic Breast Cancer Trial in Morgantown (DOXIL, Abraxane)

Completed
Has Results
  • Metastatic Breast Cancer
  • Morgantown, West Virginia
    Clinical Trials Research Unit, West Virginia University
Dec 22, 2020

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022

Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))

Recruiting
  • Invasive Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Apr 1, 2022

Cancer Trial in Canada, United States (BBI503, Capecitabine, Doxorubicin)

Completed
  • Cancer
  • Fort Wayne, Indiana
  • +7 more
Apr 4, 2022

B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)

Not yet recruiting
  • B-cell Lymphoma
  • Burkitt Lymphoma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jun 11, 2022

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
Has Results
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Multiple Myeloma, Patient Participation Trial in San Francisco, New York (Doxil, melphalan, bortezomib)

Terminated
Has Results
  • Multiple Myeloma
  • Patient Participation
  • Doxil, melphalan, bortezomib
  • San Francisco, California
  • +1 more
Jun 4, 2020

Hematologic Tumors Trial run by the NCI (Stem cell transplantation, Fludarabine, Cyclophosphamide)

Completed
Has Results
  • Hematologic Neoplasms
  • Stem cell transplantation
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 19, 2021

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Nemvaleukin and Pembrolizumab Combination
  • +6 more
  • Ventura, California
  • +7 more
Aug 5, 2022